Emotional State Questionnaire (EST-Q)

Abstract

The Emotional State Questionnaire (EST-Q) is a standardized self-report psychometric instrument designed to screen for, identify, and evaluate common psychiatric and psychological symptoms, focusing predominantly on depressive disorders, generalized anxiety, panic-agoraphobia manifestations, asthenia or fatigue, and sleep disturbances (insomnia). Developed originally by Anu Aluoja and colleagues at the Department of Psychiatry, University of Tartu, Estonia, the EST-Q was formulated to map closely onto diagnostic criteria delineated in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and the International Classification of Diseases (ICD-10). The instrument consists of 31 symptom-oriented items that yield five primary clinical subscales: Depression, Generalized Anxiety, Agoraphobia-Panic, Fatigue (Asthenia), and Insomnia, along with supplementary somatic or illness-anxiety indicators.

Respondents evaluate the occurrence and frequency of each symptom experienced over the preceding four weeks on a 5-point Likert-type scale ranging from 0 (“not at all”) to 4 (“all the time”). Across multiple normative, clinical, and community cohorts, the EST-Q has demonstrated robust psychometric properties. Internal consistency reliability for the total scale regularly exceeds a Cronbach’s alpha of α = .88, with subscale alphas spanning from .69 to .87 (.87 for Depression, .82 for Agoraphobia-Panic, .77 for Fatigue, .76 for Insomnia, and .69 to .75 for Generalized Anxiety). Confirmatory and exploratory factor analyses consistently validate its multidimensional architecture, effectively separating general distress into distinguishable affective, physiological, cognitive, and autonomic clusters. The EST-Q exhibits high concurrent validity with legacy gold standards such as the Beck Depression Inventory (BDI) and the State-Trait Anxiety Inventory (STAI), alongside remarkable discriminative power to differentiate psychiatric outpatients from non-clinical controls. Its brief administration time (5 to 10 minutes), transparent scoring paradigm, and empirically verified clinical cut-offs render it an indispensable diagnostic aid for psychiatric clinics, epidemiological surveys, occupational health screenings, and primary medical care.

Keywords

Emotional State Questionnaire, EST-Q, psychometrics, depression screening, generalized anxiety disorder, agoraphobia, panic disorder, fatigue assessment, insomnia measurement, rating scale validation

Authors

The Emotional State Questionnaire (EST-Q) was conceptualized, developed, and empirically validated by an interdisciplinary team of clinical psychiatrists, psychometricians, and epidemiologists affiliated with the Department of Psychiatry at the University of Tartu and partner public health institutions in Estonia:

• Anu Aluoja, PhD — Department of Psychiatry, Faculty of Medicine, University of Tartu, Tartu, Estonia; leading researcher in psychometrics, mood disorders, and cognitive vulnerability.
• Jakov Shlik, MD, PhD — Department of Psychiatry, University of Tartu, Estonia; later affiliated with the Royal Ottawa Mental Health Centre and the Department of Psychiatry at the University of Ottawa, Canada; renowned specialist in anxiety disorders, panic mechanisms, and psychopharmacology.
• Veiko Vasar, MD, PhD — Late Professor and Chair of the Department of Psychiatry, University of Tartu; prominent psychiatric researcher who pioneered neuropsychopharmacology and epidemiological psychiatric surveys in Northern and Eastern Europe.
• Kaja Luuk, MSc — Department of Psychiatry and Department of Psychology, University of Tartu, Tartu, Estonia; specialist in clinical psychology assessment, questionnaire standardisation, and statistical methodologies.
• Mall Leinsalu, MD, PhD — Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia, and Södertörn University, Stockholm, Sweden; leading medical demographer and psychiatric epidemiologist.

Correspondence regarding the original development and psychometric investigations is historically addressed to the Department of Psychiatry, University of Tartu, Raja 31, 50417 Tartu, Estonia.

Purpose

The fundamental purpose of the Emotional State Questionnaire (EST-Q) is to provide an efficient, psychometrically sound, self-administered diagnostic screening instrument that captures the full spectrum of common mental disorders frequently encountered in general practice, psychiatric consultations, and epidemiological inquiries. Historically, clinicians and researchers were forced to deploy multiple disjointed inventories—such as one scale for depressive symptoms, another for autonomic anxiety, and a third for insomnia or somatic exhaustion. This fragmentation burdened patients with test fatigue, increased administrative overhead, and introduced measurement inconsistencies across clinical settings. The EST-Q resolved these operational barriers by amalgamating the diagnostic cores of mood, anxiety, and asthenic syndromes into a unified, coherent questionnaire.

Clinical Applications

In clinical practice, the EST-Q serves three indispensable functions: primary triage, differential symptom mapping, and longitudinal treatment monitoring:

• Primary Triage and Screening: In primary care and general outpatient medicine, somatic complaints (such as non-restorative sleep, muscular tension, or unexplainable lethargy) frequently mask underlying affective or neurotic disorders. The EST-Q operates as a rapid screening battery that alerts general practitioners to hidden suicidal ideation, major depressive episodes, or impending panic disorder before symptoms progress to chronic dysfunction.
• Differential Symptom Profiling: Because the EST-Q incorporates distinct subscales for Depression, Anxiety, Agoraphobia-Panic, Fatigue, and Insomnia, it enables clinicians to construct a nuanced profile of patient distress. For instance, it allows the clinician to determine whether fatigue is secondary to severe sleep architecture disruption (high Insomnia score) or reflects the core neurovegetative anhedonia of major depression (high Depression score).
• Treatment Response Monitoring: Administered biweekly or monthly during pharmacological or psychotherapeutic interventions (e.g., Cognitive Behavioral Therapy (CBT) or selective serotonin reuptake inhibitors [SSRIs]), the EST-Q provides quantifiable metric tracking of symptom reduction, residual symptoms, and relapse vulnerability.

Research and Epidemiological Applications

In scientific research, the EST-Q has functioned as a central epidemiological instrument across large-scale population-based cohorts, such as the Estonian Health Interview Surveys and biobank phenotypic characterizations. Its capacity to quantify continuous symptom dimensions makes it well suited for:

• Investigating the comorbidity patterns between depression and generalized anxiety disorders.
• Genomic and biomarker association studies requiring granular phenotypic stratification of affective and neurotic spectrum traits.
• Evaluating public health burdens, psychiatric epidemiology across socio-demographic strata, and occupational burnout in high-stress vocational environments.

Psychological Construct

The EST-Q evaluates human psychological distress through a hierarchical, multidimensional construct. Rather than viewing distress as an undifferentiated general factor (e.g., general negative affectivity), the instrument explicitly recognizes that emotional suffering crystallizes into distinct yet interacting syndromal dimensions defined by modern psychiatric nosology (American Psychological Association; World Health Organization).

1. The Depression Construct

Depressive symptomatology within the EST-Q encompasses cognitive, emotional, and motivational deficits reflecting major depressive disorder. Key operationalized facets include:

• Depressed Mood and Dysphoria: Pervasive feelings of sadness (Item 1) and subjective loneliness (Item 16).
• Anhedonia: The profound inability to experience interest or pleasure in usually rewarding activities (Items 3 and 18).
• Cognitive Distortions of Worth: Excessive feelings of worthlessness (Item 5), ruminative self-accusations or guilt (Item 6), and despair regarding the future (hopelessness, Item 17).
• Suicidal Ideation: Morbid preoccupations, recurrent thoughts of death, or active suicidal impulses (Item 7), which function as critical red-flag risk metrics in clinical evaluation.

2. The Generalized Anxiety Construct

The anxiety construct operationalizes the core characteristics of Generalized Anxiety Disorder (GAD), emphasizing cognitive apprehension, emotional hypervigilance, and somatic motor tension:

• Apprehensive Worry: Pathological, uncontrollable worry about various real or anticipated life events (Item 23).
• Affective and Motor Restlessness: Irritability (Item 2), inner tension or the subjective inability to relax (Item 22), and psychomotor agitation characterized by the physical inability to sit still (Item 24).
• Hyperarousal and Vigilance: Pervasive fearfulness (Item 20) and exaggerated startle responses to minor sensory inputs (Item 26).

3. The Agoraphobia-Panic Construct

This subscale captures the sudden, acute paroxysms of autonomic discharge characteristic of panic attacks alongside the avoidance conditioning seen in agoraphobia:

• Autonomic Panic Surges: Discrete episodes of catastrophic somatic distress involving tachycardia/palpitations, acute dyspnea (shortness of breath), presyncope (faintness), and terrifying visceral sensations (Item 25).
• Agoraphobic Situational Avoidance: Anticipatory dread and avoidance behavior related to locations where escape might be difficult or help unavailable, such as being outside the home alone (Item 27), traversing open spaces or busy streets (Item 28), congregating in public settings with fear of collapsing/fainting (Item 29), and riding public transportation or automobiles (Item 30).

4. The Fatigue (Asthenia) Construct

Chronic fatigue often serves as an ambiguous cross-cutting symptom shared between neurasthenia, depressive disorders, and medical illnesses. The EST-Q isolates fatigue as an empirical sub-construct encompassing:

• Physical and cognitive anergy (Item 4: “Fatigue or loss of energy”).
• Psychomotor retardation and subjective mental sluggishness (Item 9: “Feeling slowed down”).
• Non-restorative recovery dynamics (Item 19: “Rest does not restore strength”).
• Vulnerability to rapid exhaustion under minor physical or intellectual demands (Item 21: “Being easily fatigued”).

5. The Insomnia Construct

Sleep disruption is a primary transdiagnostic axis. The EST-Q specifically isolates the three classic chronological parameters of insomnia:

• Initial Insomnia: Difficulty initiating sleep or prolonged sleep latency (Item 10).
• Middle Insomnia: Restless, fragmented, or disturbed nocturnal maintenance (Item 11).
• Terminal Insomnia: Premature early morning awakenings without the ability to return to sleep (Item 12).

6. Somatic and Hypochondriacal Markers

Beyond these five core subscales, the instrument captures vegetative alterations (hypersomnia, anorexia, hyperphagia; Items 13, 14, 15) and somatic preoccupation or hypochondriacal anxiety (Item 31: pervasive fear of having a catastrophic, unrecognized medical disease), yielding an exhaustive assessment of neurotic distress.

Theoretical Framework

The theoretical architecture of the EST-Q sits at the convergence of psychiatric descriptive nosology, cognitive theories of emotional processing, and the tripartite model of anxiety and depression.

The Tripartite Model and Structural Commonalities

During the 1990s, clinical psychology sought to disentangle why self-report measures of depression and anxiety exhibited correlations as high as r = .70 to .80. The Tripartite Model developed by Clark and Watson (1991) postulated that emotional disorders share a broad, overarching dimension of General Negative Affectivity (neuroticism), but diverge along two distinct axes:

• Low Positive Affectivity: Specific to depression, manifesting as anhedonia, lethargy, and loss of zest for life.
• Physiological Hyperarousal: Specific to anxiety (especially panic), characterized by somatic autonomic surges, dizziness, and neuromuscular tension.

Aluoja and colleagues designed the EST-Q with these theoretical insights in mind. By intentionally providing specific symptom anchors for panic-related autonomic sensations, situational agoraphobic dread, and pure anhedonic depression, the EST-Q preserves the distinct variance of each syndrome while allowing the shared negative affectivity to be captured across the instrument as a whole.

Nosological Alignment: DSM-IV and ICD-10

Unlike purely psychometric inventories derived from lexical hypothesis paradigms, the EST-Q is fundamentally a criterion-anchored clinical instrument. Its items were authored by experienced academic psychiatrists to correspond directly with the operationalized diagnostic criteria set forth in the American Psychiatric Association’s DSM-IV and the World Health Organization’s ICD-10 for Major Depressive Episode, Generalized Anxiety Disorder, Panic Disorder, Agoraphobia, and Neurasthenia. Consequently, the questionnaire bridges the gap between statistical latent traits and real-world clinical decision-making.

Cognitive-Behavioral Feedback Loops

The scale incorporates cognitive formulations of anxiety and affective maintenance (Beck, 1976; Clark, 1986). In agoraphobia and panic, the catastrophic misinterpretation of bodily sensations (such as interpreting palpitations as an impending cardiac arrest or fainting spell) leads directly to avoidant escape behaviors. This dynamic is mapped directly by Item 25 (panic attack with frightening bodily sensations) paired with Items 27–30 (avoidance of streets, buses, and solo outings). Similarly, depressive cognitive triads—negative thoughts about the self (worthlessness, guilt), the world (loneliness), and the future (hopelessness)—are systematically assessed through Items 5, 6, 16, and 17.

Validity

The psychometric validity of the EST-Q has been corroborated through rigorous investigations involving psychiatric patient cohorts, somatic medical patients, and large general population samples.

Construct and Structural Validity

Construct validity is substantiated by the scale’s capacity to delineate separate yet correlated psychopathological spectra. When subjected to multivariable statistical procedures, items authored to assess specific diagnostic domains reliably cluster together with negligible cross-loading onto unrelated emotional domains. For example, depressive anhedonia (Item 3) and cognitive despair (Item 17) load strongly on the Depression factor, while autonomic panic (Item 25) and transportation fears (Item 30) load unambiguously on the Agoraphobia-Panic factor.

Convergent Validity

Convergent validity has been established by correlating EST-Q subscales with internationally recognized psychometric instruments:

• Beck Depression Inventory (BDI): The EST-Q Depression subscale correlates strongly with the BDI, demonstrating Pearson correlation coefficients typically ranging between r = .76 and r = .83 in clinical and student samples.
• State-Trait Anxiety Inventory (STAI): The EST-Q Anxiety subscale displays robust convergent correlations with the STAI Trait (r ≈ .68 to .74) and State (r ≈ .62 to .70) anxiety indices.
• Montgomery-Åsberg Depression Rating Scale (MADRS): Clinician-rated depressive severity correlates significantly with the self-reported EST-Q Depression scores (r > .70), demonstrating that self-evaluations under the EST-Q accurately reflect objective clinical evaluations.

Discriminant and Known-Groups Validity

Discriminant validity has been documented across distinct diagnostic cohorts. In the initial validation study conducted by Aluoja et al. (1999), the EST-Q exhibited marked sensitivity to clinical status:

• Patients diagnosed with Major Depressive Disorder achieved mean EST-Q Depression scores significantly higher than both healthy controls and patients diagnosed with uncomplicated Panic Disorder (p < .001).
• Patients diagnosed with Agoraphobia and Panic Disorder scored markedly higher on the Agoraphobia-Panic subscale than patients with uncomplicated major depression or non-clinical participants.
• Patients diagnosed with primary Generalized Anxiety Disorder demonstrated the highest elevation on the Anxiety subscale while exhibiting moderate, non-predominant elevations on panic items.

Criterion and Predictive Validity

Receiver Operating Characteristic (ROC) analyses demonstrate outstanding predictive accuracy in classifying DSM-defined clinical cases versus non-cases. The area under the ROC curve (AUC) for the Depression subscale regularly surpasses .90 against structured clinical interviews (such as the MINI or SCAN). Optimal diagnostic threshold scores have been established across validation cohorts:

• Depression Subscale: A cut-off score of ≥ 12 indicates probable clinically significant depressive disorder, maximizing sensitivity (> 80%) and specificity (> 85%).
• Anxiety Subscale: A cut-off score of ≥ 12 identifies probable Generalized Anxiety Disorder.
• Agoraphobia-Panic Subscale: A cut-off score of ≥ 6 or ≥ 7 reflects clinically notable agoraphobic avoidance and autonomic panic pathology.
• Fatigue Subscale: A cut-off score of ≥ 7 suggests clinically disabling exhaustion or asthenia.
• Insomnia Subscale: A cut-off score of ≥ 6 denotes marked sleep maintenance or initiation disturbance requiring targeted intervention.

Reliability

Reliability evaluations demonstrate that the EST-Q possesses solid internal consistency and temporal stability across repeated clinical administrations.

Internal Consistency Reliability

In the seminal psychometric investigation by Aluoja et al. (1999) involving psychiatric outpatients and healthy controls, internal consistency coefficients (Cronbach’s alpha, α) revealed exemplary homogeneity for the composite scale and its respective clinical dimensions:

• Total EST-Q Scale: α = .88
• Depression Subscale (8 items): α = .87
• Agoraphobia-Panic Subscale (5 items): α = .82
• Fatigue Subscale (variable 4–5 items): α = .77
• Insomnia Subscale (3 items): α = .76
• Anxiety Subscale (6 items): α = .69 (in later expanded cohort studies, this value consistently ranged between .72 and .78)

Corrected item-total correlations for key diagnostic items (e.g., sadness, loss of interest, feelings of worthlessness, panic attacks) routinely exceed r = .50, confirming that each item contributes substantial unique and shared variance to its target construct.

Test-Retest Stability

In stable non-clinical and maintenance-phase clinical populations evaluated over a two- to four-week test-retest interval, the EST-Q exhibits high intraclass correlation coefficients (ICC) and Pearson correlation coefficients, generally falling between r = .78 and r = .86 for the primary subscales. These metrics confirm that the questionnaire reflects stable emotional traits in the absence of treatment while maintaining sufficient sensitivity to capture rapid symptomatic changes following effective pharmacotherapy or psychotherapy.

Factor Analysis

The latent structure of the EST-Q has been subjected to extensive Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) across diverse sample groups, including clinical outpatients, university students, and large general population registries.

Exploratory Factor Structure

Initial principal components and principal axis factoring with Promax (oblique) and Varimax rotations consistently reveal a clear multi-factor structure accounting for over 50% to 58% of the total cumulative variance. The extracted dimensions clearly correspond to the theoretical subscales:

• Factor 1: Depression / Core Affective Distress: Strong primary factor loadings (> .60) for feelings of sadness (Item 1), loss of interest or pleasure (Item 3), feelings of worthlessness (Item 5), self-accusations (Item 6), suicidal thoughts (Item 7), loneliness (Item 16), hopelessness (Item 17), and inability to enjoy things (Item 18).
• Factor 2: Agoraphobia-Panic: High, uncontaminated loadings (> .65) for panic attacks with autonomic distress (Item 25), fear of being outside alone (Item 27), open space/street anxiety (Item 28), fear of public fainting (Item 29), and travel avoidance (Item 30).
• Factor 3: Generalized Anxiety and Tension: Substantial loadings for irritability (Item 2), inner fearfulness (Item 20), muscle tension/inability to relax (Item 22), excessive worry (Item 23), motor restlessness (Item 24), and startle response (Item 26).
• Factor 4: Asthenia / Fatigue: Clear loading profile for fatigue or loss of energy (Item 4), feelings of being slowed down (Item 9), non-restorative rest (Item 19), and easy fatigability (Item 21).
• Factor 5: Sleep Disruption / Insomnia: Distinct, high factor loadings (> .75) for difficulty falling asleep (Item 10), restless sleep (Item 11), and early morning awakening (Item 12).

Confirmatory Factor Analysis and Model Fit

Subsequent confirmatory investigations utilizing structural equation modeling (SEM) in broad demographic samples have evaluated competing models: a unidimensional general distress model, an uncorrelated orthogonal model, and a correlated five-factor first-order model. The correlated five-factor model demonstrated superior fit indices across conventional psychometric benchmarks:

• Comparative Fit Index (CFI): ≥ .92 to .95
• Tucker-Lewis Index (TLI): ≥ .91 to .94
• Root Mean Square Error of Approximation (RMSEA): ≤ .045 to .055 (90% CI: .041–.058)
• Standardized Root Mean Square Residual (SRMR): ≤ .048

These CFA findings confirm that while emotional distress syndromes share inter-factor correlations (with the highest latent correlations emerging between Depression and Fatigue, φ ≈ .65, and between Depression and Generalized Anxiety, φ ≈ .62), collapsing them into a single undifferentiated “distress” metric causes substantial loss of clinically vital information.

Instrument / Measurement Tool

The technical parameters and administrative specifications of the Emotional State Questionnaire are detailed below:

• Instrument Name: Emotional State Questionnaire (EST-Q)
• Alternative / Successor Titles: EST-Q-2 (updated variant)
• Assessment Type: Standardized self-report symptom questionnaire
• Target Population: Adolescents and adults (ages 16 to 75+) presenting in clinical or research contexts
• Time Horizon / Recall Window: The preceding four weeks (“during the past month”)
• Administration Time: Approximately 5 to 10 minutes
• Total Item Count: 31 items
• Response Format: 5-point Likert-type frequency scale:
  • 0 = Not at all (mitte üldse)
  • 1 = Seldom (harva)
  • 2 = Sometimes (mõnikord)
  • 3 = Often (sageli)
  • 4 = All the time (pidevalt)
• Subscale Item Composition:
  • Depression (8 items): Items 1, 3, 5, 6, 7, 16, 17, 18. (Maximum subscale score = 32)
  • Anxiety / Generalized Anxiety (6 items): Items 2, 20, 22, 23, 24, 26. (Maximum subscale score = 24)
  • Agoraphobia-Panic (5 items): Items 25, 27, 28, 29, 30. (Maximum subscale score = 20)
  • Fatigue / Asthenia (4–5 items): Items 4, (5/8/9), 19, 21. Standard 4-item core: 4, 9, 19, 21. (Maximum subscale score = 16 to 20)
  • Insomnia (3 items): Items 10, 11, 12. (Maximum subscale score = 12)
  • Supplementary / Somatization Items: Items 8, 13, 14, 15, 31 (evaluating cognitive concentration, hypersomnia, appetite loss, hyperphagia, and hypochondriacal health anxiety).
• Scoring Algorithm: Subscale scores are calculated by summing the raw item values within each diagnostic domain. Higher scores reflect greater symptom frequency and clinical severity.
• Established Clinical Cut-off Scores:
  • Depression: ≥ 12
  • Anxiety: ≥ 12
  • Agoraphobia-Panic: ≥ 6–7
  • Fatigue: ≥ 7
  • Insomnia: ≥ 6

Permissions, Fee, and Test Year

The Emotional State Questionnaire was formally introduced in 1999 by Anu Aluoja and co-workers through their validation publication in the Nordic Journal of Psychiatry.

The EST-Q was conceived as a public-domain scientific assessment for academic research, psychiatric training, and non-commercial clinical practices. It is free of commercial licensing fees for scientific and healthcare applications. Researchers and clinicians are authorized to utilize the tool provided that proper academic attribution is cited in resulting reports, presentations, and publications. Health systems, digital application vendors, or proprietary pharmaceutical trials seeking commercial integration or translation into other languages are advised to seek formal institutional consent via the Department of Psychiatry at the University of Tartu, Estonia.

References

• Aluoja, A., Shlik, J., Vasar, V., Luuk, K., & Leinsalu, M. (1999). Development and psychometric properties of the Emotional State Questionnaire, a self-report questionnaire for depression and anxiety. Nordic Journal of Psychiatry, 53(6), 443–449. https://doi.org/10.1080/080394899427692
• Aluoja, A., Leinsalu, M., Shlik, J., Vasar, V., & Luuk, K. (2004). Symptoms of depression and anxiety in Estonia: Prevalence and sociodemographic correlates. Social Psychiatry and Psychiatric Epidemiology, 39(4), 269–277. https://doi.org/10.1007/s00127-004-0735-5
• American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). American Psychiatric Association. https://doi.org/10.1176/ajp.152.8.1228
• Beck, A. T. (1976). Cognitive therapy and the emotional disorders. International Universities Press.
• Clark, D. M. (1986). A cognitive approach to panic. Behaviour Research and Therapy, 24(4), 461–470. https://doi.org/10.1016/0005-7967(86)90011-2
• Clark, L. A., & Watson, D. (1991). Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. Journal of Abnormal Psychology, 100(3), 316–336. https://doi.org/10.1037/0021-843X.100.3.316
• Leinsalu, M. (2002). Social determinants of self-reported emotional well-being in Estonia. Social Science & Medicine, 55(4), 603–613. https://doi.org/10.1016/S0277-9536(01)00191-1
• World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. World Health Organization. https://apps.who.int/iris/handle/10665/37951

Items of the Scale